Integrilin Supplies Sufficient For 30% Growth In 2002, Millennium Says
Executive Summary
Millennium's Integrilin supplies are sufficient to meet projections for 30% sales growth this year despite problems at Schering-Plough's fill/finish facility, Millennium says
You may also be interested in...
Schering Rebetol Is Only “Medically Necessary” Oral Product In FDA Decree
Schering-Plough's Rebetol (ribavirin capsules) is the only oral product deemed "medically necessary" under the company's consent decree with FDA
Schering Rebetol Is Only “Medically Necessary” Oral Product In FDA Decree
Schering-Plough's Rebetol (ribavirin capsules) is the only oral product deemed "medically necessary" under the company's consent decree with FDA
Millennium Gets Cor Hospital Sales Corps To Aid Oncology Program
Millennium's acquisition of Cor Therapeutics will give the company a hospital care sales force that it could use as a base for commercializing its oncology program